Abstract: A computer system for integrating trading account security with associate investment policy (AIP) governance is provided. The system includes a processor and a receiver. A received trade request may include an associate social security number, an associate name, a security name, a last security purchase data, and a broker dealer name. The employee may be a private side employee. The processor may use a series of containers in electronic communication with a database or database engine to determine that the trade request is industry compliant and employer regulations compliant. When the trade request is determined to be non-compliant, then the processor may electronically message or e-mail the employee 1) a trade denial and 2) insider trading mitigation messages. Following a determination that the trade request is fully compliant; the processor may transmit the trade request to an employer trading platform and prompt the associate to execute the trade request.

Abstract: A system for integrating trading account security with associate investment policy (AIP) governance is provided, including a processor and a receiver for receiving an associate trade request. The trade request may include an associate social security number and name, a name of a security, a last security purchase data, the last data for the security, and a broker dealer name. The processor may determine that the employee is a private side employee and then use a series of containers in electronic communication with a database or engine to determine industry and employer regulations compliance, after which the processor may transmit the request to an employer trading platform and may include an instruction to allow executing the trade request within a pre-determined time period and prompting the associate with a selectable option to execute the trade request.

Abstract: A system for integrating trading account security with associate investment policy (AIP) governance is provided. The system includes a processor, a receiver, and a series of containers. The receiver may receive an associate trade request including an associate social security number (SSN), an associate name, a name of a security to which the trade request is directed, a last security purchase data, the last security purchase data associated with the security, and a broker dealer name. The employee may be a private side employee. The system may include a series of containers for storing microservices. The containers communicate with a database engine. The trade request may be industry compliant and employer regulations compliant. The processor may transmit a fully compliant trade request to an employer platform. Following receipt of a trade request confirmation from the employer platform, the associate trading platform may execute the trade request.

Abstract: A passive circuit component includes an edge having a low line edge roughness (LER). A method for manufacturing the passive circuit component includes a self-aligned double patterning (SADP) etch process using a tri-layer process flow. The tri-layer process flow includes use of an underlayer, hard mask, and photoresist. The passive circuit component made by this method achieves improved mismatch between like components due to the low LER.

Abstract: Disclosed herein are NLRP3 inflammasome inhibitors and compositions thereof. Also disclosed herein are methods including administering a therapeutically effective amount of a composition comprising at least one NLRP3 inflammasome inhibitor to a subject in need thereof.

Abstract: Described herein are orally-bioavailable nucleoside analogs and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of coronavirus infections, including SARS-CoV-2 infection.

Abstract: Described herein are orally-bioavailable nucleoside analogs and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of coronavirus infections, including SARS-CoV-2 infection.

Abstract: The present disclosure provides broad-spectrum carbapenem derivatives and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such derivatives and/or compositions.

Abstract: Described herein are hepatitis B capsid assembly modulator compounds of formula (I) and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of hepatitis B.

Abstract: Described herein are certain boron-containing compounds, compositions, preparations and their use as modulators of the transpeptidase function of bacterial penicillin-binding proteins and as antibacterial agents. In some embodiments, the compounds described herein inhibit penicillin-binding proteins. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

Abstract: Described herein are hepatitis B capsid assembly modulators and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of hepatitis B.

Abstract: Described herein are hepatitis B capsid assembly modulators and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of hepatitis B.

Abstract: Image analytics systems, methods, and computer program products to autonomously analyze an image to identify and detect features in the image, such as the horizon, and/or identify and detect objects of interest therein, such as, smoke or possible smoke. The image is captured, for example, by RGB cameras, and depicts a scene to be analyzed. The intelligent image analytic system is configured to provide alerts and/or other information to one or more concerned parties and/or computing systems to take an appropriate response.

Abstract: Described herein are hepatitis B capsid assembly modulators and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of hepatitis B.

Abstract: Described herein are orally-bioavailable nucleoside analogs and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of coronavirus infections, including SARS-CoV-2 infection.

Abstract: Described herein are hepatitis B capsid assembly modulators and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of hepatitis B.

Abstract: Disclosed herein are crystalline forms of ((2-Ethylbutanoyl)oxy)methyl (R)-2-hydroxy-3-propionamido-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylate. Also disclosed herein are methods of treating a bacterial with a crystalline form of ((2-Ethylbutanoyl)oxy)methyl (R)-2-hydroxy-3-propionamido-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylate.

Abstract: Described herein are certain boron-containing compounds, compositions, preparations and their use as modulators of the transpeptidase function of bacterial penicillin-binding proteins and as antibacterial agents. In some embodiments, the compounds described herein inhibit penicillin-binding proteins. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

Abstract: Described herein are certain boron-containing compounds, compositions, preparations and their use as modulators of the transpeptidase function of bacterial penicillin-binding proteins and as antibacterial agents. In some embodiments, the compounds described herein inhibit penicillin-binding proteins. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

Abstract: Described herein are hepatitis B capsid assembly modulators and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of hepatitis B.